Los Angeles, CA51 Active Studies

Osteogenesis Imperfecta Clinical Trials in Los Angeles, CA

Find 51 actively recruiting osteogenesis imperfecta clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

51
Active Trials
42
Sponsors
75,294
Enrolling

Recruiting Osteogenesis Imperfecta Studies in Los Angeles

About Osteogenesis Imperfecta Clinical Trials in Los Angeles

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 51 osteogenesis imperfecta clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 75,294 participants. Research is being sponsored by Pfizer, Duke University, National Cancer Institute LAO and 39 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Los Angeles — FAQ

Are there osteogenesis imperfecta clinical trials in Los Angeles?

Yes, there are 51 osteogenesis imperfecta clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 51 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated July 13, 2026 from ClinicalTrials.gov